{'output': [['Transgene Sa', 'ORG', 'Operate_In', 'Gdynia Newsroom', 'ORG/REG'], ['TG4010', 'PRODUCT', 'Participates_In', 'Phase 2 Trial', 'EVENT'], ['TG4010', 'PRODUCT', 'Control', 'Transgene Sa', 'ORG'], ['TG4010', 'PRODUCT', 'Relate_To', 'NSCLC', 'CONCEPT'], ['TG4010', 'PRODUCT', 'Plus', 'Nivolumab', 'PRODUCT'], ['TG4010', 'PRODUCT', 'Plus', 'Chemotherapy', 'PRODUCT'], ['Phase 2 Trial', 'EVENT', 'Enroll', 'Up to 39 patients', 'CONCEPT'], ['Phase 2 Trial', 'EVENT', 'Happen', 'In USA and Europe', 'GPE'], ['First Results', 'EVENT', 'Expect', 'In H2 2018', 'DATE']]}